Challenges of Genomics and Proteomics in Nephrology

REFERENCES

• Mueller GA, Mueller CA, Dihazi H. Clinical proteomics—on the long way from bench to bedside. Nephrol Dial Transplant. 2007;22:1297–1300.
   PubMedGoogle Scholar
• Gupta P, Lee KH. Genomics and proteomics in process development: Opportunities and challenges. Trends Biotechnol. 2007;25:324–330.
   PubMed Web of Science ®Google Scholar
• Lee PS, Lee KH. Genomic analysis. Curr Opin Biotechnol. 2000;11:171–175.
   PubMed Web of Science ®Google Scholar
• Chee M, Yang R, Hubbell E, Berno A, Huang XC, Stern D. Accessing genetic information with high density DNA arrays. Science. 1996;274:610–614.
   PubMed Web of Science ®Google Scholar
• Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature. 2000;405:827–836.
   PubMed Web of Science ®Google Scholar
• Beaudet AL, Belmont JW. Array-based DNA diagnostics: Let the revolution begin. Annu Rev Med. 2008;59:113–129.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Wang L, Kambham N, Montgomery K, Mason V, Vogelmann SU, Gene expression in the normal adult human kidney assessed by complementary DNA microarray. Mol Biol Cell. 2004;15:649–656.
   PubMed Web of Science ®Google Scholar
• Ritz E. Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol. 2002;13:2384–2398.
   PubMedGoogle Scholar
• Hildebrandt F, Strahm B, Nothwang HG, Gretz N, Schnieders B, Singh-Sawhney I, Molecular genetic identification of families with juvenile nephronophthisis type 1: Rate of progression to renal failure. Kidney Int. 1997;51:261–269.
   PubMedGoogle Scholar
• Vuong MT, Lundberg S, Gunnarsson I, Wramner L, Seddighzadeh M, Hahn-Zoric M, Genetic variation in the transforming growth factor-β1.gene is associated with susceptibility to IgA nephropathy. Nephrol Dial Transplant. 2009; doi:10.1093/ndt/gfp079.
   PubMedGoogle Scholar
• Yoon HJ, Chin HJ, Na KY, Chae DW, Kim S, Jeon US, Association of angiotensin II type 2 receptor gene A1818T polymorphism with progression of immunoglobulin a nephropathy in Korean patients. J Korean Med Sci. 2009;24(Suppl. 1):s38–s43.
   Google Scholar
• Chin HJ, Cho HJ, Lee TW, Na KY, Yoon HJ, Chae DW, The heme oxygenase-1 genotype is a risk factor to renal impairment of IgA nephropathy at diagnosis, which is a strong predictor of mortality. J Korean Med Sci. 2009;24(Suppl. 1):s30–s37.
   Google Scholar
• Caridi G, Bertelli R, Carrea A, Diduca M, Catarsi P, Artero M, Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol. 2001;12:2742–2746.
   PubMed Web of Science ®Google Scholar
• Pezzolesi MG, Poznik GD, Mychaleckyj JC, Paterson AD, Barati MT, Klein JB, Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes mellitus. Diabetes. 2009;58:1403–1410.
   PubMed Web of Science ®Google Scholar
• Supavekin S, Zhang W, Kucherlapati R, Differential gene expression following early renal ischemia-reperfusion. Kidney Int. 2003;63:1714–1724.
   PubMed Web of Science ®Google Scholar
• Green DR, Kroemer G. Pharmacologic manipulation of cell death: Clinical applications insight?. J Clin Invest. 2005;115:2610–2617.
   PubMed Web of Science ®Google Scholar
• Jones J, Libermann TA. Genomics of renal cell cancer: The biology behind and the therapy ahead. Clin Cancer Res. 2007;13(Suppl. 2):s685–s692.
   Google Scholar
• Kopper L, Timar J. Genomics of renal cell cancer—does it provide breakthrough?. Pathol Oncol Res. 2006;12:5–11.
   PubMedGoogle Scholar
• Peng J. Gygi SP. Proteomics: The move to mixtures. J Mass Spect. 2001;36:1083–1091.
   PubMed Web of Science ®Google Scholar
• Thongboonkerd V. Proteomics in nephrology: Current status and future directions. Am J Nephrol. 2004 24:360–378.
   Google Scholar
• Knepper MA. Proteomics and the kidney. J Am Soc Nephrol. 2002;13:1398–1408.
   PubMed Web of Science ®Google Scholar
• Arthur JM. Proteomics. Curr Opin Nephrol Hypertens. 2003;12:423–430.
   PubMed Web of Science ®Google Scholar
• Dihazi H, Mueller GA. Urinary proteomics: A tool to discover biomarkers of kidney diseases. Proteomics. 2007;4:39–50.
   PubMedGoogle Scholar
• Fliser D, Novak J, Thongboonkerd V, Argilés À, Jankowski V, Girolami MA, Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol. 2007;18:1057–1071.
   PubMed Web of Science ®Google Scholar
• Arthur JM, Thongboonkerd V, Scherzer JA, Cai J, Pierce WM, Klein JB. Differential expression of proteins in renal cortex and medulla: A proteomic approach. Kidney Int. 2002;62:1314–1321.
   PubMed Web of Science ®Google Scholar
• Xu BJ, Shyr Y, Liang X, Ma LJ, Donnert EM, Roberts JD, Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J Am Soc Nephrol. 2005;16:2967–2975.
   PubMed Web of Science ®Google Scholar
• Kislinger T, Cox B, Kannan A, Chung C, Hu P, Ignatchenko A, Global survey of organ and organelle protein expression in mouse: Combined proteomic and transcriptomic profiling. Cell. 2006;125:173–186.
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Miyazaki K, Kamijo K, Tsugita A, Kamiie J, Xu B, Proteome database of normal human glomerulus: Two-dimensional electrophoresis profiling and constructing of XML-based database. J Am Soc Nephrol. 2003;14(Suppl.):283A.
   PubMedGoogle Scholar
• Vidal BC, Bonventre JV, Hong SI. Towards the application of proteomics in renal disease diagnosis. Clin Science. 2005;109:421–430.
   PubMed Web of Science ®Google Scholar
• Decramer S, Wittke S, Mischak H, Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Met. 2006;12:398–400.
   Google Scholar
• Schaub S, Wilkins J, Weiler T, Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int. 2004;65:323–332.
   PubMed Web of Science ®Google Scholar
• Thongboonkerd V, McLeish KR, Arthur JM, Klein JB. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int. 2002;62:1461–1469.
   PubMed Web of Science ®Google Scholar
• Pieper R, Gatlin CL, McGrath AM, Makusky AJ, Mondal M, Seonarain M, Characterization of the human urinary proteome: A method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics. 2004;4:1159–1174.
   PubMed Web of Science ®Google Scholar
• Sun W, Li F, Wu S, Wang X, Zheng D, Wang J, Gao Y. Human urine proteome analysis by three separation approaches. Proteomics. 2005;5:4994–5001.
   PubMed Web of Science ®Google Scholar
• Castagna A, Cecconi D, Sennels L, Rappsilber J, Guerrier L, Fortis F, Exploring the hidden human urinary proteome via ligand library beads. J Proteome Res. 2005;4:1917–1930.
   PubMed Web of Science ®Google Scholar
• Adachi J, Kumar C, Zhang Y, Olsen JV, Mann M. The human urinary proteome contains more than 1500 proteins including a large proportion of membranes proteins. Genome Biol. 2006;7:R80.
   PubMed Web of Science ®Google Scholar
• Hewitt SM, Dear J, Star RA. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol. 2004;15:1677–1689.
   PubMed Web of Science ®Google Scholar
• Zhou H, Pisitkun T, Aponte A, Yuen PS, Hoffert JD, Yasuda H, Exosomal fetuin-A identified by proteomics: A novel urinary biomarker for detecting acute kidney injury. Kidney Int. 2006;70:1847–1857.
   PubMed Web of Science ®Google Scholar
• Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens. 2008;17:127–132.
   PubMed Web of Science ®Google Scholar
• Park MR, Wang EH, Jin DC, Cha JH, Lee KH, Yang CW, Establishment of a 2-D human urinary proteomic map in IgA nephropathy. Proteomics. 2006;6:1066–1076.
   PubMed Web of Science ®Google Scholar
• Shui HA, Huang TZ, Ka SM, Chen PH, Lin YF, Chen A. Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2008;23:176–185.
   PubMedGoogle Scholar
• Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int. 2005;67:2313–2320.
   PubMed Web of Science ®Google Scholar
• Weissinger EM, Wittke S, Kaiser T, Haller H, Bartel S, Krebs R, Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int. 2004;65:2426–2434.
   PubMed Web of Science ®Google Scholar
• Sharma K, Lee S, Han S, Lee S, Francos B, McCue P, Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics. 2005;5:2648–2655.
   PubMed Web of Science ®Google Scholar
• Dihazi H, Mueller GA, Lindner S, Meyer M, Asif AR, Oellerich M, Strutz F. Characterization of diabetic nephropathy by urinary proteomic analysis: Identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients. Clin Chem. 2007;53:1636–1645.
   PubMed Web of Science ®Google Scholar
• Wittke S, Haubitz M, Walden M, Rohde F, Schwarz A, Mengel M, Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am J Transplant. 2005;5:2479–2488.
   PubMed Web of Science ®Google Scholar
• Rossing K, Mischak H, Parving HH, Christensen PK, Walden M, Hillmann M, Kaiser T. Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns. Kidney Int. 2005;68:193–205.
   PubMed Web of Science ®Google Scholar
• Schiffer E, Mischak H, Vanholder RC. Exploring the uremic toxins using proteomic technologies. Contrib Nephrol. 2008;160:159–171.
   PubMed Web of Science ®Google Scholar
• Sarto C, Deon C, Doro G, Hochstrasser DF, Mocarelli P, Sanchez JC. Contribution of proteomics to the molecular analysis of renal cell carcinoma with an emphasis on manganese superoxide dismutase. Proteomics. 2001;1:1288–1294.
   PubMedGoogle Scholar
• Celis JE, Ostergaard M, Rasmussen HH, Gromov P, Gromova I, Varmark H, A comprehensive protein resource for the study of bladder cancer. Electrophoresis. 1999;20:300–309.
   PubMedGoogle Scholar
• Kim HJ, Sohng I, Hwang CH, Park JY. Cytokeratin-20 and seminal vesicle secretory protein VI as possible marker proteins in urinary bladder preneoplastic lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Int J Urol. 2006;13(2):142–147.
   PubMedGoogle Scholar
• Tolson JP, Flad T, Gnau V, Dihazi H, Hennenlotter J, Beck A, Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis. Proteomics. 2006;6:697–708.
   PubMed Web of Science ®Google Scholar
• Rasmussen HH, Orntoft TF, Wolf H, Celis JE. Towards a comprehensive database of proteins from the urine of patients with bladder cancer. J Urol. 1996;155:2113–2119.
   PubMed Web of Science ®Google Scholar